Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.

N Jewel SamadderNathan FosterRyan P McMurrayCarol A BurkeElena StoffelPriyanka KanthRohit DasMarcia Roxana Cruz-Correa Eduardo VilarGautam MankaneyNavtej ButtarSelvi ThirumurthiDanielle K TurgeonMichael SossenheimerMichelle WestoverEllen RichmondAsad UmarGary Della'ZannaLuz M RodriguezEva SzaboDavid ZahriehPaul J Limburg

Published in: Gut (2022)

NCT02961374.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
early onset
open label
chronic rhinosinusitis
risk factors
placebo controlled
randomized controlled trial
study protocol